Clinical Management of Acne: The Role of Healite II Phototherapy

by Francesca Perino | Registered TCM Practitioner & Clinical Director

Acne vulgaris is a multifaceted inflammatory condition that requires a structured, evidence-based approach. At Mi Skn Clinic, we focus on the underlying pathology of acne, utilizing Healite II Low-Level Light Therapy (LLLT) as a cornerstone of our clinical protocols.

Unlike generic LED devices, Healite II uses targeted wavelengths to modulate cellular activity, assisting in the management of active congestion and supporting the skin’s structural recovery.

The Targeted Wavelengths

Our protocols exclusively utilize two specific wavelengths supported by peer-reviewed literature for their efficacy in managing acneic skin.

415nm (Blue Light) | Microbial Regulation

The 415nm wavelength is clinically utilized for its antimicrobial properties. It targets the C. acnes bacteria within the sebaceous follicles.

• Mechanism: Blue light triggers a photochemical reaction in the porphyrins produced by acne bacteria, leading to their neutralization without thermal damage to the surrounding tissue.

• Clinical Application: Used primarily during the acute phase to reduce the microbial load on the skin's surface.

830nm (Near-Infrared) | Inflammatory Modulation

The 830nm wavelength penetrates to the deeper dermal layers, where it interacts with the mitochondria to enhance cellular ATP production.

• Mechanism: This wavelength is used to down-regulate inflammatory markers and stimulate the wound-healing cascade.

• Clinical Application: Essential for managing deep-seated inflammatory lesions and reducing the duration of post-inflammatory erythema (redness) that often follows a breakout.

Evidence-Based Foundations

We base our treatment parameters on established clinical research. Below are the core studies that inform our approach:

• Combined 415nm and 830nm Efficacy: A study published in the Journal of Cosmetic and Laser Therapy demonstrated that the combination of these two wavelengths resulted in a significant reduction in both inflammatory and non-inflammatory acne lesions.
  🔗 Read the study: Combination Blue and NIR LED Therapy for Acne

• Wound Healing and Recovery: Research by Dr. R. Glen Calderhead highlights the ability of 830nm light to accelerate tissue repair and reduce inflammatory responses.
  🔗 Read the study: 830nm LED LLLT and Wound Healing

• Safety and Clinical Review: A comprehensive review in the Journal of Clinical and Aesthetic Dermatology supports LLLT as a safe, non-invasive adjunct for managing inflammatory skin conditions.
  🔗 Read the review: Phototherapy with LEDs in Dermatology

Integration into Mi Skn Clinic Protocols

At Mi Skn Clinic, Healite II is integrated into a broader management plan that may include clinical skincare and naturopathic support to address the internal drivers of acne.

• Post-Procedural Management: We utilize 830nm light following clinical extractions or chemical peels to assist in the resolution of erythema and to support immediate tissue recovery.

• Acute Management Phase: For clients experiencing active inflammatory flares, we may recommend a series of sessions focusing on 415nm light to manage the bacterial environment.

• Maintenance and Skin Resilience: Ongoing use of 830nm light helps to support the skin’s barrier function and overall dermal health, which is critical for long-term acne management.

Professional Considerations

As with all clinical procedures, individual results are subject to biological variation.

• Suitability: A comprehensive skin analysis is required to determine if Healite II is appropriate for your specific skin type and condition.

• Expectations: While LLLT is a powerful tool for managing symptoms and supporting healing, it is most effective when used as part of a holistic, multi-modality treatment plan.

• Safety Profile: Healite II is a TGA-cleared medical device. It is non-thermal, non-invasive, and does not require downtime.

About Francesca Perino

Francesca is a Registered Chinese Medicine Practitioner and the Clinical Director of Mi Skn Clinic. She focuses on combining evidence-based technology with traditional holistic health to support long-term skin health.

👉 View Professional Profile

Clinical Review by Francesca Perino (AHPRA: CMR0001727209)